Showing 13,541 - 13,560 results of 39,063 for search '(( 5 ((step decrease) OR (mean decrease)) ) OR ( 100 ((nn decrease) OR (a decrease)) ))', query time: 1.31s Refine Results
  1. 13541
  2. 13542
  3. 13543
  4. 13544
  5. 13545

    Baseline characteristics of the study sample<sup>β</sup>μ. by Osama Mohamed Ibrahim (12006954)

    Published 2024
    “…Pharmacists in Active Group A (37.2%) and Active Group B (32.3%) most commonly intervened by recommending the cessation of medication, while the most common intervention in the Control Group was recommending a decrease in dose (29.8%). The mean cost reduction per patient was highest in Active Group A (31.3 ±11.8 $), followed by Active Group B (20.8 ±8.6 $) and the Control Group (19.6 ±9.5 $). …”
  6. 13546

    The flow diagram of the study (CONSORT, 2010). by Osama Mohamed Ibrahim (12006954)

    Published 2024
    “…Pharmacists in Active Group A (37.2%) and Active Group B (32.3%) most commonly intervened by recommending the cessation of medication, while the most common intervention in the Control Group was recommending a decrease in dose (29.8%). The mean cost reduction per patient was highest in Active Group A (31.3 ±11.8 $), followed by Active Group B (20.8 ±8.6 $) and the Control Group (19.6 ±9.5 $). …”
  7. 13547

    Table_1_Incidence and risk factors of severe acute high-altitude illness in healthy adults first entering the northern Tibetan Plateau of over 5,000 m.DOC by Chun Gao (622218)

    Published 2024
    “…</p>Conclusion<p>Living at lower altitudes and having a decreased lymphocyte level were the risk factors of severe AHAI in healthy adults first entering the plateau of over 5,000 m.…”
  8. 13548
  9. 13549

    Systemic 5-FU treatment caused delayed increases in auditory brainstem response (ABR) inter-peak latencies P2-P1 and P3-P1 by Ruolan Han (35102)

    Published 2011
    “…At the later time points day 14 and day 56, both P2-P1 and P3-P1 inter-peak latency values of 5-FU-treated animals show average increases of more than 0.13 ms, whereas the same inter-peak latency values of sham-treated controls show average decreases or an increase of less than 0.04 ms. …”
  10. 13550
  11. 13551
  12. 13552
  13. 13553

    Rank-Order stability with longer conversations. by Grgur Kovač (19484728)

    Published 2024
    “…<p>Rank-order value stability (<i>Mean</i>±<i>SE</i>) following conversations of different length for the Mixtral-8x7B-Instruct-v0.1 model simulating fictional characters (correlation of simulated participants’ value expression in different contexts). …”
  14. 13554
  15. 13555
  16. 13556

    Silencing KDM2A enhances angiogenic tubulogenesis. by Wasia Rizwani (369727)

    Published 2014
    “…<p>(A) HUVEC cells were transfected with either control siRNA or KDM2A siRNA (75 pmol). 24 hr later, cells were plated on matrigel in complete media (asynchronous) or with or without 100 ng/ml VEGF. …”
  17. 13557

    COVID19 effect on essential services. by Admas Abera (11821659)

    Published 2024
    “…On the other hand, the mean number of patients screened for diabetes and hypertension during the pandemic increased by more than 1014 (β: 1014.5; 95%CI: 103.07, 1925.92) and 610 patients (β: 611.21; 95%CI: 302.42, 919.99), respectively. …”
  18. 13558
  19. 13559

    Supplementary Material for: Oral L-Arginine (5 g/day) for 14 Days Improves Microcirculatory Function in Healthy Young Women and Healthy and Type 2 Diabetes Mellitus Elderly Women by Costa G. (3075237)

    Published 2021
    “…All patients underwent biochemical analysis (fasting glycemia and lipidogram), arterial blood pressure, nailfold videocapillaroscopy (capillary diameters, functional capillary density [FCD], peak red blood cell velocity [RBCV<sub>max</sub>] after 1 min ischemia, time to reach peak RBCV [TRBCV<sub>max</sub>]), and venous occlusion plethysmography (vasoreactivity), before and after 14 days of oral supplementation with L-arginine (5 g/day). <b><i>Results:</i></b> L-Arginine did not change fasting glycemia and lipidogram, but it decreased systolic, diastolic, and mean arterial pressure in elderly women, increased RBCV<sub>max</sub> in all groups, and did not decrease TRBCV<sub>max</sub> in T2DME. …”
  20. 13560